Haryana Govt. seeks details on sale of abusive drugs

Chandigarh

To curb the misuse of medical intoxicants in Haryana, the state government has issued various directions, including preparation of periodic reports, about the sale of narcotics and psychotropic substances used by addicts. According to the directions issued by the state drugs controller, food and drugs administration (FDA) department, all wholesalers and authorized stockists would have to submit a monthly report of procurement, stock, sale of such intoxicants to the drug control officers of their area by the fifth day of every month via e-mail. The drugs control officers have been told to verify the reports submitted to them and share them with their colleagues for further verification. The state government has also prohibited the sale of formulations containing diphenoxylate HCL and its combinations in the state under Section 26-A of the Drugs and Cosmetic Act , 1940.These decisions have been taken by the state government following the directions of the Punjab and Haryana high court to ensure that the drugs used by addicts, will not be easily available at medical stores. These directions were passed during the hearing of a case pertaining to drug abuse in Punjab. Observing that the problem of drug abuse was also prevalent in Haryana, Justice Surya Kant had directed the the state government to inform the HC about the steps taken to control the drug menace. Further raising questions over sale of pharmaceutical drugs at various chemist shops in the state illegally, the HC had observed that there appeared to be no coordination between drug controllers and the police to check that.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices